MICHAEL A. WEINER, M.D. - Corporate Board Profile

SIGA TECHNOLOGIES INC

Filing Date	Source Excerpt
2003-12-05	Michael A. Weiner, M.D 57 Director The members of the Audit Committee since June 29, 2001 are Drs. Mehmet C. Oz and Michael A. Weiner, neither of whom is or has been an employee of SIGA. The members of the Compensation Committee since June 29, 2001 are Drs. Mehmet C. Oz and Michael A. Weiner, neither of whom is or has been an employee of SIGA.
2004-11-22	Michael A. Weiner, M.D. * 57 Director The Audit Committee, which currently consists of directors Paul G. Savas, Mehmet C. Oz and Michael A. Weiner, held four meetings during 2003. The Compensation Committee, which currently consists of directors Paul G. Savas, Mehmet C. Oz and Michael A. Weiner, held no meetings during 2003. The Nominating and Corporate Governance Committee (the "Nominating Committee"), which currently consists of directors Paul G. Savas, Mehmet C. Oz and Michael A. Weiner, was formed in March 2004 and as such held no meetings in 2003.
2005-04-29	Michael A. Weiner, M.D. has served as a director of SIGA since April 19, 2001. Dr. Weiner is the Hettinger Professor of Pediatrics at Columbia University College of Physicians and Surgeons since 1996. Dr. Weiner is also the Director of Pediatric Oncology at New York Presbyterian Hospital. Dr. Weiner was a director of Nexell Therapeutics, Inc. (f/k/a VimRx) from March 1996 to February 1999. Dr. Weiner is a 1972 graduate of the New York State Health Sciences Center at Syracuse and was a post graduate student at New York University and Johns Hopkins University.
2006-11-20	Michael A. Weiner, M.D. has served as a director of SIGA since April 19, 2001. ... The Nominating and Corporate Governance Committee (the "Nominating Committee"), which currently consists of directors Judy S. Slotkin, James J. Antal and Michael A. Weiner, was formed in March 2004 and held three meetings in 2005. ... Directors who are not currently receiving compensation as officers or employees of the Company or any of its affiliates receive $1,000 per meeting for board meetings ...
2007-04-27	Michael A. Weiner, M.D. has served as a director of SIGA since April 19, 2001. Dr. Weiner is the Hettinger Professor of Pediatrics at Columbia University College of Physicians and Surgeons since 1996.
2007-06-15	Michael A. Weiner, M.D. 161 Fort Washington Ave. New York, NY 10032 ....................................... 142,500(13) * *
2008-04-09	Michael A. Weiner, M.D. has served as a director of SIGA since April 2001...The Compensation Committee currently consists of directors Steven L. Fasman, Paul G. Savas and Michael A. Weiner...The Nominating and Corporate Governance Committee currently consists of directors Judy S. Slotkin, James J. Antal and Michael A. Weiner...During the fiscal year ending December 31, 2007, Michael A. Weiner, M.D. received fees earned or paid in cash of $10,500 and option awards of $22,120.
2009-04-08	Michael A. Weiner, M.D. has served as a director of SIGA since 2001. Dr. Weiner is the Hettinger Professor of Pediatrics at Columbia University College of Physicians and Surgeons since 1996.
2010-04-12	Michael A. Weiner, M.D. has served as a director of SIGA since 2001. Dr. Weiner has been the Hettinger Professor of Pediatrics at Columbia University College of Physicians and Surgeons since 1996.
2011-04-12	Michael A. Weiner, M.D. has served as a director of SIGA since 2001. Dr. Weiner has been the Hettinger Professor of Pediatrics at Columbia University College of Physicians and Surgeons since 1996.
2012-04-27	Michael A. Weiner, M.D. has served as a director of SIGA since 2001. Dr. Weiner has been the Hettinger Professor of Pediatrics at Columbia University College of Physicians and Surgeons since 1996.
2013-04-16	Michael A. Weiner, M.D. has served as a director of SIGA since 2001. Dr. Weiner has been the Hettinger Professor of Pediatrics at Columbia University College of Physicians and Surgeons since 1996.
2014-04-15	Michael A. Weiner, M.D. has served as a director of SIGA. The Nominating and Corporate Governance Committee (the Nominating Committee), which consisted of directors James J. Antal, Michael J. Bayer, Frances Fragos Townsend and Michael A. Weiner, held one meeting in 2013. The Board of Directors has determined that each of the members of the Nominating Committee is independent within the meaning of the NASDAQ listing standards. During the fiscal year ending December 31, 2013, the directors of SIGA received total compensation as shown in the following table: Michael Weiner, M.D. 35,000 cash fees and 53,550 stock awards totaling 88,550.